Taysha Gene Therapies Growth Metrics (2022-2025) | TSHA

Growth Metrics Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
EBITDA Margin Growth (1y) -774041.00-546802.00-270390.00-458610.00-36141.00-93901.00-110604.00-53498.00-21726.0056,830.00
EBITDA Margin Growth (3y) -831908.00-583874.00
EBITDA Margin (QoQ) -289689.00-213015.00177,382.00-448720.00-62450.0063,397.00-10838.00-26250.00-120210.0046,694.0046,268.005,522.00-41654.00
EBIT Margin Growth (1y) -774041.00-546802.00-270390.00-458610.00-36141.00-93901.00-110604.00-53498.00-21726.0056,830.00
EBIT Margin Growth (3y) -831908.00-583874.00
EBIT Margin (QoQ) -289689.00-213015.00177,382.00-448720.00-62450.0063,397.00-10838.00-26250.00-120210.0046,694.0046,268.005,522.00-41654.00
EBT Margin Growth (1y) -786075.00-561520.00-281069.00-463734.00-29021.00-76113.00-98191.00-48551.00-20926.0053,398.00
EBT Margin Growth (3y) -836022.00-584235.00
EBT Margin (QoQ) -289844.00-212735.00175,941.00-459436.00-65289.0067,716.00-6724.00-24724.00-112381.0045,637.0042,917.002,901.00-38057.00
Enterprise Value Growth (1y) 36.11%34.54%-344.68%-64.30%-96.18%-284.16%3.74%3.40%5.93%-80.87%-88.31%
Enterprise Value Growth (3y) -5.65%-65.68%-100.51%
Enterprise Value (QoQ) 30.62%46.36%-137.88%27.83%28.92%-264.39%12.11%13.82%-39.19%8.69%11.79%16.08%-167.62%4.93%
FCF Margin Growth (1y) -785792.00-632883.00-323812.0050,275.00-7273.00-117965.00-82684.00-45767.00-37304.0092,549.00
FCF Margin Growth (3y) -830369.00-658299.00
FCF Margin (QoQ) -179889.00-268732.00-381035.0043,863.00-26979.0040,339.00-6948.00-13685.00-137672.0075,621.0029,969.00-5222.00-7819.00
Interest Coverage Ratio Growth (1y) 83.69%63.85%53.22%44.90%-6,861.40%-4,757.79%-9,668.19%-3,876.23%-34.38%-99.49%-110.20%
Interest Coverage Ratio Growth (3y) -148.03%-227.22%-357.97%
Interest Coverage Ratio (QoQ) 39.21%47.42%-75.11%70.86%-34.74%31.97%-106.26%-3,582.03%5.97%-36.79%16.04%-24.44%-39.58%-44.14%
Net Margin Growth (1y) -786211.00-561548.00-492783.00-289587.00-33094.00-85496.00103,955.00-225370.00-22984.0052,844.00
Net Margin Growth (3y) -842288.00-594200.00
Net Margin (QoQ) -289922.00-212766.00175,978.00-459499.00-65260.00-144001.00379,173.00-203006.00-117662.0045,450.0049,849.00-620.00-41834.00
Operating Margin Growth (1y) -774041.00-546802.00-270390.00-458610.00-36141.00-93901.00-110604.00-53498.00-21726.0056,830.00
Operating Margin Growth (3y) -831908.00-583874.00
Operating Margin (QoQ) -289689.00-213015.00177,382.00-448720.00-62450.0063,397.00-10838.00-26250.00-120210.0046,694.0046,268.005,522.00-41654.00
Return on Assets Growth (1y) 100.0069.0093.0039.00-10.00-6.005.0014.00
Return on Assets (QoQ) 23.00-18.0053.0042.00-8.006.00-1.00-7.00-5.0018.008.00
Return on Capital Employed Growth (1y) 241.00153.00237.00-318.00-14.00-5.0010.0020.00
Return on Capital Employed (QoQ) 72.00-74.00555.00-313.00-15.0010.000.00-9.00-6.0025.0010.00
Return on Equity Growth (1y) 2,277.00-2027.00-567.00-347.00467.00-7.0034.0042.00
Return on Equity (QoQ) 4,754.00-1429.00-211.00-836.00450.0031.009.00-23.00-24.0072.0017.00
Return on Sales Growth (1y) -7861.00-5615.00-2811.00-4637.00-290.00-761.00-982.00-486.00-209.00534.00-160.00
Return on Sales Growth (3y) -8360.00-5842.00-3953.00
Return on Sales (QoQ) -2898.00-2127.001,759.00-4594.00-653.00677.00-67.00-247.00-1124.00456.00429.0029.00-381.00-238.00